Retour
34
25
28
60
55
Fourchette du Jour
65,10 €
66,93 €
Fourchette 52 Semaines
54,11 €
89,98 €
Volume
3 515 949
Moyenne 50J / 200J
70,43 €
/
72,55 €
Clôture Précédente
65,94 €
Historique des Prix
Tendances Financières
Comparaison Sectorielle
vs médiane du secteur Healthcare (627 pairs)
| Métrique | Action | Médiane du Secteur |
|---|---|---|
| P/E | 31,1 | 0,3 |
| P/B | 9,5 | 2,9 |
| ROE % | 34,5 | 3,7 |
| Net Margin % | 17,9 | 3,8 |
| Rev Growth 5Y % | 17,5 | 10,0 |
| D/E | 0,5 | 0,2 |
Objectif de Cours des Analystes
Hold
85,82 €
+28.9%
Low: 72,00 €
High: 95,00 €
P/E Prévisionnel
26,5
BPA Prévisionnel
2,49 €
Croissance BPA (est.)
+0,0%
CA Est.
5,2 B
Estimations de Bénéfices
| Période | BPA Est. | CA Est. | Analystes |
|---|---|---|---|
| FY2030 |
4,87 €
4,78 € – 5,07 €
|
8,4 B | 2 |
| FY2029 |
4,19 €
4,11 € – 4,36 €
|
7,4 B | 4 |
| FY2028 |
3,57 €
3,19 € – 3,97 €
|
6,6 B | 6 |
Points Clés
Revenue grew 17,47% annually over 5 years — strong growth
Earnings grew 45,14% over the past year
ROE of 34,50% indicates high profitability
Net margin of 17,94% shows strong profitability
Generating 1,08B in free cash flow
P/E of 31,06 — premium valuation
Croissance
Revenue Growth (5Y)
17,47%
Revenue (1Y)15,60%
Earnings (1Y)45,14%
FCF Growth (3Y)45,06%
Qualité
Return on Equity
34,50%
ROIC16,54%
Net Margin17,94%
Op. Margin19,56%
Sécurité
Debt / Equity
0,51
Current Ratio1,88
Interest Coverage0,00
Valorisation
P/E Ratio
31,06
P/B Ratio9,46
EV/EBITDA29,01
Dividend Yield0,00%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | 15,60% | Revenue Growth (3Y) | 13,45% |
| Earnings Growth (1Y) | 45,14% | Earnings Growth (3Y) | 24,27% |
| Revenue Growth (5Y) | 17,47% | Earnings Growth (5Y) | 40,13% |
| Profitability | |||
| Revenue (TTM) | 4,66B | Net Income (TTM) | 836,30M |
| ROE | 34,50% | ROA | 13,19% |
| Gross Margin | 60,10% | Operating Margin | 19,56% |
| Net Margin | 17,94% | Free Cash Flow (TTM) | 1,08B |
| ROIC | 16,54% | FCF Growth (3Y) | 45,06% |
| Safety | |||
| Debt / Equity | 0,51 | Current Ratio | 1,88 |
| Interest Coverage | 0,00 | Dividend Yield | 0,00% |
| Valuation | |||
| P/E Ratio | 31,06 | P/B Ratio | 9,46 |
| P/S Ratio | 5,57 | PEG Ratio | 0,66 |
| EV/EBITDA | 29,01 | Dividend Yield | 0,00% |
| Market Cap | 25,98B | Enterprise Value | 26,45B |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 4,66B | 4,03B | 3,62B | 2,91B | 2,45B |
| Net Income | 836,30M | 576,20M | 541,50M | 341,20M | 216,90M |
| EPS (Diluted) | 2,09 | 1,42 | 1,30 | 0,80 | 0,51 |
| Gross Profit | 2,80B | 2,44B | 2,29B | 1,88B | 1,68B |
| Operating Income | 911,80M | 600,00M | 597,70M | 391,20M | 265,80M |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 6,34B | 6,48B | 6,26B | 5,39B | 4,93B |
| Total Liabilities | 3,59B | 4,38B | 4,20B | 3,26B | 2,89B |
| Shareholders' Equity | 2,75B | 2,10B | 2,07B | 2,13B | 2,04B |
| Total Debt | 1,39B | 2,59B | 2,59B | 2,15B | 2,16B |
| Cash & Equivalents | 917,70M | 606,10M | 566,30M | 642,30M | 1,05B |
| Current Assets | 4,03B | 4,30B | 4,43B | 3,67B | 3,68B |
| Current Liabilities | 2,14B | 2,93B | 1,56B | 1,84B | 720,80M |
Scores de Stratégies
This stock passed the criteria for 5 strategies
Score = fit strength (0–100)
Rank = position among all matches
Custom
Cash Flow Compounder
#757 of 1052
Custom
Capital Light Compounder
#184 of 218
#141 of 157
Custom
Balanced Risk
#23 of 151
Custom
Lower Risk
#26 of 140
Activité Récente
Entré
Cash Flow Compounder
Mar 24, 2026
Entré
Capital Light Compounder
Mar 24, 2026
Entré
Growth Investing (Philip Fisher)
Mar 24, 2026
Entré
Balanced Risk
Mar 24, 2026
Entré
Lower Risk
Mar 24, 2026